A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.

PHASE3CompletedINTERVENTIONAL

Enrollment

601

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Hypertension

Interventions

DRUG

Aliskiren

Aliskiren 300 mg

DRUG

Valsartan

Valsartan 320 mg

DRUG

Hydrochlorothiazide (HCTZ)

Hydrochlorothiazide (HCTZ) 12.5-25 mg

Trial Locations (4)

Investigative Centers, San Diego

Investigative Centers, Canada

Investigative Centers, Germany

Investigative Centers, Netherlands